The NIH seeks a firm-fixed-price contract for 210 G-Rex100 cell culture systems (3-pack boxes) used in patient cell therapy manufacturing for clinical trials, with each unit featuring a 100 cm² gas-permeable membrane and 450 mL media capacity. The acquisition is a competitive small business set-aside, and the total value is not expected to exceed $350,000. Offerors must provide technical capability, price, past performance, and delivery schedule, along with shipping costs, delivery terms, and SAM registration. The government will make a best-value award based on these evaluation factors.